Catherine Madigan
Chief Tech/Sci/R&D Officer at SYNDAX PHARMACEUTICALS, INC.
Net worth: 743 215 $ as of 2024-04-29
Profile
Catherine Madigan is currently the Chief Medical Officer at Syndax Pharmaceuticals, Inc. She previously worked as the Senior Medical Director at Alnylam Pharmaceuticals, Inc. and as the Vice President & Head-Clinical Development at Syros Pharmaceuticals, Inc. Dr. Madigan completed her undergraduate degree at Dartmouth College and obtained her doctorate degree from Keck School of Medicine of USC.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-07 | 36,131 ( 0.04% ) | 743 215 $ | 2024-04-29 |
Catherine Madigan active positions
| Companies | Position | Start |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Former positions of Catherine Madigan
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| SYROS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Catherine Madigan
| Dartmouth College | Undergraduate Degree |
| Keck School of Medicine of USC | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Catherine Madigan